Policy | August 03, 2022
PIB: Pharmaceutical industry in Maharashtra
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
The total financial outlay of the scheme is Rs.500 crore for a period of five years from 2021-22 to 2025-26.
Abbott has recently received the US Food and Drug Administration nod to use its DBS device for treatment-resistant depression
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
The acquisition is subject to customary closing conditions and necessary regulatory approvals. The financial terms of the transaction are confidential
A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business
India has the second-largest number of adults with diabetes globally, after China
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
He will be leading the business, operations, P&L, and growth strategy for StanPlus
Subscribe To Our Newsletter & Stay Updated
